TRPV3 and nonpapillary renal cell carcinoma: Taken together, TRPV3 was a potential immunomodulatory factor in ccRCC, and targeting TRPV3 might inhibit the immunosuppressive effect of Treg cells and increase the efficacy of immunotherapy.